Xenetic Biosciences Inc (XBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 08-2013 | 12-2012 | 08-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,573 | 4,906 | 0 | 11,137 | 0 |
| Receivables | N/A | 256 | 256 | 212 | 212 |
| TOTAL | $2,777 | $5,330 | $256 | $11,545 | $212 |
| Non-Current Assets | |||||
| PPE Net | 119 | 153 | 0 | 122 | 0 |
| Intangibles | 13,220 | 13,983 | 0 | 13,704 | 0 |
| Other Non-Current Assets | 199 | 0 | 0 | 0 | 0 |
| TOTAL | $13,539 | $14,136 | $0 | $13,826 | $0 |
| Total Assets | $16,316 | $19,466 | $256 | $25,371 | $212 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,248 | 1,623 | 0 | 803 | 0 |
| Accrued Expenses | 1,410 | 1,912 | 0 | 543 | 0 |
| TOTAL | $2,699 | $3,590 | $0 | $1,400 | $0 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 56 | 0 | 0 | 0 | 0 |
| TOTAL | $3,137 | $3,258 | $0 | $3,193 | $0 |
| Total Liabilities | $5,835 | $6,848 | $0 | $4,593 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 38 | N/A | N/A | N/A | N/A |
| Common Shares | 150 | 1,306 | 0 | 1,305 | 0 |
| Retained earnings | -75,624 | -58,307 | 0 | -49,728 | 0 |
| Other shareholders' equity | 294 | 619 | 0 | 635 | 0 |
| TOTAL | $10,481 | $12,618 | $0 | $20,779 | $0 |
| Total Liabilities And Equity | $16,316 | $19,466 | $0 | $25,371 | $0 |